Kyleena (Levonorgestrel)

Kyleena, a hormonal intrauterine contraceptive, is indicated for the following clinical uses.

• Long‑acting reversible contraception: provides up to five years of highly effective pregnancy prevention for women of reproductive age.
• Prevention of unintended pregnancy: offers a reliable, low‑maintenance option for women seeking to avoid conception.
• Management of heavy menstrual bleeding: can reduce the volume and duration of menstrual bleeding in some users.
• Non‑daily contraceptive method: delivers continuous hormone release, eliminating the need for daily pills or frequent dosing.

• Levonorgestrel released from the intrauterine system acts locally on the endometrium and cervical mucus. It thickens cervical mucus, creating a barrier to sperm penetration, suppresses endometrial proliferation, and in many users inhibits ovulation. The localized delivery results in high uterine concentrations with minimal systemic exposure, providing effective contraception while reducing systemic side effects.

Kyleena may be associated with a range of adverse reactions, which are generally categorized by frequency.

Common Side Effects

• Irregular bleeding: spotting or changes in menstrual pattern.
• Amenorrhea: absence of periods.
• Pelvic pain: discomfort after insertion.
• Cramping: uterine cramps during the first cycles.
• Headache: mild to moderate.
• Breast tenderness: mild soreness or swelling.

Serious or Rare Side Effects

• Uterine perforation: rare injury during insertion.
• Expulsion: device may be expelled from the uterus.
• Infection: pelvic inflammatory disease or severe infection.

Prior to insertion and during use, several precautions should be observed to ensure safety and effectiveness.

• Screen for pregnancy: confirm the patient is not pregnant before insertion.
• Assess uterine anatomy: avoid in women with uterine anomalies or fibroids that distort the cavity.
• Check for active infection: contraindicated in the presence of pelvic or cervical infection.
• Hormone sensitivity: do not use in individuals with known levonorgestrel hypersensitivity.
• Contraindicated conditions: avoid in women with breast cancer or other hormone‑dependent malignancies.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levonorgestrel may interact with other medicines, influencing its contraceptive efficacy.

Major Interactions (Avoid)

• Enzyme inducers (e.g., rifampin, carbamazepine): may reduce levonorgestrel effectiveness.
• Antifungal azoles (e.g., ketoconazole): may increase systemic levonorgestrel exposure.
• Protease inhibitors (e.g., ritonavir): potential alteration of hormone levels.

Moderate Interactions (Monitor Closely)

• Certain antibiotics (e.g., tetracycline): may slightly affect contraceptive reliability.
• Herbal supplements (e.g., St. John’s wort): may reduce hormonal efficacy.